Podaljšana diagnostična obravnava bolnice z rakom pljuč

V prispevku poročamo o kliničnem primeru bolnice s slučajno odkrito sumljivo lezijo v pljučih, pri kateri je prišlo do pomembno podaljšane diagnostične obravnave in odloženega pričetka zdravljenja zaradi sočasne obravnave poškodbe hrbtenice in okužbe s COVID

Aspects of social well-being regarding people\u27s health

Družbenega razvoja in blaginje družbe ni mogoče opisati zgolj z ustvarjenim BDP. Kompleksna večdimenzionalna mera, ki odraža družbeni vpliv na blagostanje človeka in človekovega okolja, je nov OECD-jev ˝indeks boljšega življenja˝. Njegov sestavni del je tudi komponenta, ki opredeljuje zdravstveno stanje ljudi v državi. Raziskave kažejo, da so med vplivnimi dejavniki, ki vplivajo na zdravstveno stanje ljudi in vsiljujejo oz. pogojujejo določene vzorce v življenjskih navadah ljudi, pomembne tudi družbeno-ekonomske determinante - določeni dejavniki tveganja za nastanek kroničnih bolezni in s tem v povprečju krajše življenjske dobe, so v nižjih družbenih slojih izraženi močneje kot v višjih družbenih slojih. Iz opravljene raziskave izhaja, da je tako tudi v Sloveniji - v družbenih slojih, ki odražajo neenakomerno porazdelitev bogastva, moči, blaginje ... med različnimi družbenimi skupinami, lahko identificiramo tudi različno zdravstveno stanje ljudi, pripadnikov teh družbenih slojev.Societyʼs social development and well-being cannot be described in terms of GDP only. A complex multi-dimensional measure that reflects the social impact on human welfare and human environment is the OECDʼs new ˝Your Better Life Index˝, which defines the state of peopleʼs health in the country using an integrated component. Research indicates that, among the influential factors affecting the health status of people and creating certain patterns in humansʼ lifestyles, socio-economic determinants are also importantspecific risk factors for chronic diseases affecting average life expectancy are expressed more strongly in lower social classes than in the higher social strata. The research results described in this paper confirm the thesis that this is also the situation in Slovenia: Social classes reflect the uneven distribution of wealth, power, and welfare among different social groups as well as differences in people\u27s health statuses

Priporočila za obravnavo bolnikov s pljučnim rakom

In 2019, the Recommendations for the management of patients with lung cancer were published bringing much-needed standardisation of diagnosis and treatment to improve survival of patients with lung cancer. Three years after the original Recommendations were published, the update of the Recommendations brings the most innovations in the chapter on systemic treatment of patients with lung cancer. This reflects the remarkable progress made in the field of understanding the oncogenesis and biology of lung cancer and thus the development of new drugs. The burden of lung cancer remains high, as lung cancer is still the most common cause of cancer related death in our country and worldwide. Lung cancer is responsible for one of five cancer-related deaths. Almost one third of patients with lung cancer do not receive any oncological treatment, either because of poor performance status, comorbidities or the extent of the disease. Half of the patients have metastatic disease at diagnosis, resulting in only small improvements in survival despite advances in the treatment of lung cancer patients. These data remind us that if we are to make major shifts in the management of lung cancer patients, we will need to take different approaches. The most promising seems to be the detection of early stages of lung cancer which offers the best treatment results. The Recommendations written here are guidelines for the management of patients with lung cancer. Only with comprehensive multidisciplinary treatment approach, the best outcome from the prognostically unfavourable disease can be offered.Leta 2019 so bila objavljena Priporočila za obravnavo bolnikov s pljučnim rakom, ki so v slovenski prostor vnesla prepotrebno poenotenje diagnostike in zdravljenja z namenom izboljšanja preživetja bolnikov s pljučnim rakom. Posodobitev Priporočil tri leta po izidu izvirnika prinaša največ novosti v poglavju o sistemskem zdravljenju bolnikov s pljučnim rakom. To kaže na izjemen napredek na področju razumevanja onkogeneze in biologije pljučnega raka ter s tem razvoja novih zdravil. Breme pljučnega raka ostaja veliko, saj je pljučni rak pri nas in v svetu še vedno najpogostejši vzrok smrti zaradi raka. Za vsako peto smrt zaradi raka je odgovoren pljučni rak. Skoraj tretjina bolnikov s pljučnim rakom ne prejme specifičnega onkološkega zdravljenja, bodisi zaradi slabega stanja zmogljivosti, spremljajočih bolezni ali obsega bolezni. Polovica bolnikov ima ob diagnozi razsejano bolezen, zaradi česar izboljšanje preživetja z malimi koraki sledi napredku v zdravljenju bolnikov s pljučnim rakom. Ti podatki nas opominjajo, da se bomo morali za velike premike v obravnavi bolnikov s pljučnim rakom lotiti drugačnih pristopov. Kot najbolj obetavno se ponuja zgodnje odkrivanje bolezni, ko so možnosti ozdravitve pljučnega raka najboljše. Zapisana Priporočila so usmeritev za obravnavo bolnikov s pljučnim rakom. Le s sodobnim multidisciplinarnim pristopom obravnave lahko bolniku ponudimo zdravljenje, ki mu omogoča najboljši izhod prognostično neugodne bolezni

Recommendations for diagnosis and treatment of patients with lung cancer

In 2019, the Recommendations for the management of patients with lung cancer were published bringing much-needed standardisation of diagnosis and treatment to improve survival of patients with lung cancer. Three years after the original Recommendations were published, the update of the Recommendations brings the most innovations in the chapter on systemic treatment of patients with lung cancer. This reflects the remarkable progress made in the field of understanding the oncogenesis and biology of lung cancer and thus the development of new drugs. The burden of lung cancer remains high, as lung cancer is still the most common cause of cancer related death in our country and worldwide. Lung cancer is responsible for one of five cancer-related deaths. Almost one third of patients with lung cancer do not receive any oncological treatment, either because of poor performance status, comorbidities or the extent of the disease. Half of the patients have metastatic disease at diagnosis, resulting in only small improvements in survival despite advances in the treatment of lung cancer patients. These data remind us that if we are to make major shifts in the management of lung cancer patients, we will need to take different approaches. The most promising seems to be the detection of early stages of lung cancer which offers the best treatment results. The Recommendations written here are guidelines for the management of patients with lung cancer. Only with comprehensive multidisciplinary treatment approach, the best outcome from the prognostically unfavourable disease can be offered